HK-based pharma firm Chi-Med raises $100m from General Atlantic

HK-based pharma firm Chi-Med raises $100m from General Atlantic

Laboratory equipment. Photo: Pixabay

Chinese biopharmaceutical company Hutchinson China MediTech Limited (Chi-Med) has entered into a definitive agreement to sell shares worth $100 million to New York-based growth equity firm General Atlantic.